Abstract
The aim of our study was to report about the clinical outcomes of patients who underwent major surgery for cancer and developed COVID-19 in the postoperative period. A retrospective and observational study was done in the Surgical Oncology Division of a tertiary care cancer hospital in North-East India. The study period was from 1st April 2020 to 31st December 2021. Patients with a confirmed diagnosis of cancer who underwent a major surgery and developed COVID-19 in the postoperative period, within the same hospital stay were included in the study. Data was obtained from a prospectively maintained database and case records. Descriptive statistics were used to state the results in median values, range and percentages. A total of 22 patients developed COVID-19 in the postoperative period during the study period out of a total of 1402 patients operated during that time period (1.57%). The have been followed up for a median period of 16 months (range 2 to 18 months). The median age at presentation was 50 years (range 25 to 74 years). The incidence of co-morbidities was 27.3%. The median duration of ICU stay was 3 days (range 0 to 9 days) and median duration of hospital stay was 22 days (range 9 to 55 days).. The postoperative mortality rate was 18.2%. COVID-19 in the postoperative period in patients undergoing major abdominal and thoracic surgeries for cancer caused high postoperative mortality and prolonged hospital stay.
Similar content being viewed by others
Data Availability
Data is available with the corresponding author.
References
Cucinotta D, Vanelli M (2020) WHO Declares COVID-19 a Pandemic. Acta Biomed 91(1):157–160. Published 2020 Mar 19. https://doi.org/10.23750/abm.v91i1.9397
Barakbulletin (2020) First corona case in Assan: 52 year tested positive in Siclar Medical College [Internet]. https://www.barakbulletin.com/en_US/first-corona-case-in-assam-52-year-old-tested-positive-in-silchar-medical-college/. Accessed 3 Mar 2022
COVIDSurg Collaborative (2020) Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study [published correction appears in Lancet. 2020 Jun 9:]. Lancet 396(10243):27–38. https://doi.org/10.1016/S0140-6736(20)31182-X
Carrier FM, Amzallag É, Lecluyse V et al (2021) Postoperative outcomes in surgical COVID-19 patients: a multicenter cohort study. BMC Anesthesiol 21(1):15. Published 2021 Jan 12. https://doi.org/10.1186/s12871-021-01233-9
Lei S, Jiang F, Su W et al (2020) Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection. EClinicalMedicine 21:100331. Published 2020 Apr 5. https://doi.org/10.1016/j.eclinm.2020.100331
Haffner MR, Le HV, Saiz AM et al (2021) Postoperative in-hospital morbidity and mortality of patients with COVID-19 infection compared with patients without COVID-19 infection. JAMANetwOpen 4(4):e215697. https://doi.org/10.1001/jamanetworkopen.2021.5697
Al-Quteimat OM, Amer AM (2020) The impact of the COVID-19 pandemic on cancer patients. Am J Clin Oncol 43(6):452–455. https://doi.org/10.1097/COC.0000000000000712
Ranganathan P, Sengar M, Chinnaswamy G et al (2021) Impact of COVID-19 on cancer care in India: a cohort study. Lancet Oncol 22(7):970–976. https://doi.org/10.1016/S1470-2045(21)00240-0
Shankar A, Saini D, Richa et al (2020) Cancer Care Delivery Challenges in India during the COVID-19 Era: Are We Prepared for the Postpandemic Shock?. Asia Pac J Oncol Nurs 8(1):1–4. Published 2020 Nov 21. https://doi.org/10.4103/apjon.apjon_57_20
Krishnamurthy A, Gopinath KS (2020) The need for prioritizing cancer surgeries amidst the COVID-19 pandemic. Indian J Surg Oncol 11(2):169–170. https://doi.org/10.1007/s13193-020-01080-z
Das G, Khanna S, Purkayastha J et al (2021) Impact of COVID-19 pandemic on a tertiary care center’s surgical volume and outcomes: a single institutional study from Northeast India. Indian J Surg Oncol 12(Suppl 2):265–269. https://doi.org/10.1007/s13193-021-01410-9
Deo SVS, Kumar S, Kumar N et al (2020) Guiding principles for cancer surgery during the COVID-19 pandemic. Indian J Surg Oncol 11(Suppl 1):3–10. https://doi.org/10.1007/s13193-020-01082-x
Liang W, Guan W, Chen R et al (2020) Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 21(3):335–337. https://doi.org/10.1016/S1470-2045(20)30096-6
Al-Shamsi HO, Alhazzani W, Alhuraiji A et al (2020) A practical approach to the management of cancer patients during the novel coronavirus disease 2019 (COVID-19) pandemic: an International Collaborative Group. Oncologist 25(6):e936–e945. https://doi.org/10.1634/theoncologist.2020-0213
Zhang L, Zhu F, Xie L, Wang C, Wang J, Chen R, Jia P, Guan HQ, Peng L, Chen Y et al (2020) Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan. China Ann Oncol 31:894–901. https://doi.org/10.1016/j.annonc.2020.03.296
Minotti C, Tirelli F, Barbieri E, Giaquinto C, Donà D (2020) How is immunosuppressive status affecting children and adults in SARS-CoV-2 infection? A systematic review. J Infect 81:e61–e66. https://doi.org/10.1016/j.jinf.2020.04.026
Cafarotti S (2020) Sars-cov2 infection and lung cancer patients: the potential role of IL17 target therapy. J Thorac Oncol 15:e101–e103. https://doi.org/10.1016/j.jtho.2020.04.015
Rali P, O'Corragain O, Oresanya L et al (2021) Incidence of venous thromboembolism in coronavirus disease 2019: an experience from a single large academic center [published correction appears in J Vasc Surg Venous Lymphat Disord. 2022 May;10(3):799]. J Vasc Surg Venous Lymphat Disord 9(3):585–591.e2. https://doi.org/10.1016/j.jvsv.2020.09.006
Chen S, Zhang D, Zheng T, Yu Y, Jiang J (2021) DVT incidence and risk factors in critically ill patients with COVID-19. J Thromb Thrombolysis 51(1):33–39. https://doi.org/10.1007/s11239-020-02181-w
Knisely A, Zhou ZN, Wu J et al (2021) Perioperative morbidity and mortality of patients with COVID-19 who undergo urgent and emergent surgical procedures. Ann Surg 273(1):34–40. https://doi.org/10.1097/SLA.0000000000004420
Chiariello GA, Bruno P, Pavone N et al (2022) Bleeding complications in patients with perioperative COVID-19 infection undergoing cardiac surgery: a single-center matched case-control study. J Cardiothorac Vasc Anesth 36(7):1919–1926. https://doi.org/10.1053/j.jvca.2021.11.013
Iba T, Levy JH, Levi M, Thachil J (2020) Coagulopathy in COVID-19. J Thromb Haemost 18(9):2103–2109. https://doi.org/10.1111/jth.14975
Author information
Authors and Affiliations
Contributions
Conceptualization: Gaurav Das, Amrita Talukdar.
Methodology: Gaurav Das, Karma Bhutia.
Data collection and formal analysis: Gaurav Das, Karma Bhutia, Amrita Talukdar.
Writing (original draft): Gaurav Das, Karma Bhutia, Amrita Talukdar.
Writing (review and editing): Gaurav Das, Abhijit Talukdar.
Corresponding author
Ethics declarations
Competing Interests
None.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Das, G., Talukdar, A., Bhutia, K. et al. Outcomes of Patients Undergoing Major Surgery for Cancer with COVID-19 in the Postoperative Period. Indian J Surg Oncol 14, 876–880 (2023). https://doi.org/10.1007/s13193-023-01797-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13193-023-01797-7